Your browser doesn't support javascript.
Remdesivir and COVID-19 - Authors' reply.
Wang, Yeming; Gu, Xiaoying; Xu, Jiuyang; Cao, Bin; Wang, Chen.
  • Wang Y; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China.
  • Gu X; Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China.
  • Xu J; Tsinghua University School of Medicine, Beijing, China.
  • Cao B; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China; Tsinghua Univ
  • Wang C; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China; Institute of
Lancet ; 396(10256): 954, 2020 10 03.
Article in English | MEDLINE | ID: covidwho-813921

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Ribonucleotides / Coronavirus Infections / Pandemics Limits: Humans Language: English Journal: Lancet Year: 2020 Document Type: Article Affiliation country: S0140-6736(20)32015-8

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Ribonucleotides / Coronavirus Infections / Pandemics Limits: Humans Language: English Journal: Lancet Year: 2020 Document Type: Article Affiliation country: S0140-6736(20)32015-8